Study of VIATORR TIPS device for liver pressure
Part of Digestive system clinical trials.
This study tests a new version of a device (VIATORR TIPS) that helps lower high blood pressure in the liver for people with cirrhosis. The device is placed to create a small channel that reroutes blood flow and reduces pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cirrhosis and high blood pressure in the portal vein (the main vein to your liver).
- You are 18 years or older.
- You do not have a blood clot in the portal vein.
- You have not had a liver transplant (but being on the waiting list is okay).
- Your doctor expects you to live at least 6 more months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a TIPS stent graft (a tiny mesh tube placed in the liver to relieve pressure) for people with cirrhosis and complications like bleeding or fluid buildup. It aims to see how well it works and if it's safe.
This trial tests a smaller version of a TIPS procedure (a tube placed in the liver to reduce pressure) for people with cirrhosis, a small liver, and a history of serious bleeding from the esophagus or stomach. The goal is to see if this tailored approach can help control bleeding while keeping the liver working as well as possible.
This pilot study is testing a new way to guide a TIPS procedure using a special fiber-optic navigation system, which may make the shunt placement more precise for patients with serious liver problems.
This trial tests if an artificial intelligence (AI) system can help guide a TIPS procedure, which is a treatment to improve blood flow in the liver. If you need this procedure and are in good enough health, you may be able to join.
This study tests whether placing a small tube (TIPS) early in people with advanced liver cancer and a vein blockage helps their other treatments work better. It is for patients who are already taking lenvatinib and immunotherapy.
This trial tests a new type of stent placed inside the liver to lower high blood pressure in the portal vein (a major vein that carries blood to the liver). It is aimed at people with cirrhosis who have serious complications like bleeding in the esophagus or stomach, or fluid buildup in the belly that does not go away. The study will see how safe and effective this stent is.
Hear when a new Ascites trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.